Generated: December 11, 2017
DrugPatentWatch Database Preview
Pentoxifylline - Generic Drug Details
« Back to Dashboard
What are the generic sources for pentoxifylline and what is the scope of pentoxifylline patent protection?
is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Apotex, Heritage Pharms Inc, Impax Labs, Mylan, Pliva, Teva, Valeant Pharms, Watson Labs, Upsher-smith Labs, and Us Pharm Holdings, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.
There are fourteen drug master file entries for pentoxifylline. Twenty suppliers are listed for this compound.
Summary for pentoxifylline
Pharmacology for pentoxifylline
Medical Subject Heading (MeSH) Categories for pentoxifylline
|Actavis Elizabeth||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||074878-001||Jul 9, 1997||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Upsher-smith Labs||PENTOXIL||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||074962-001||Mar 31, 1999||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Teva||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||075199-001||Sep 3, 1999||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Mylan||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||074425-001||Jul 8, 1997||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Us Pharm Holdings||TRENTAL||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||018631-001||Aug 30, 1984||DISCN||Yes||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Heritage Pharms Inc||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||074877-001||Jul 8, 1997||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Pliva||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||074874-001||May 25, 1999||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Valeant Pharms||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||075028-001||Jul 20, 1998||AB||RX||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Apotex||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||075191-001||Jun 9, 1999||AB||RX||No||Yes||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
|Impax Labs||PENTOXIFYLLINE||pentoxifylline||TABLET, EXTENDED RELEASE;ORAL||075093-001||Aug 10, 1999||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Expired Orange Book Patents for Generic Ingredient: pentoxifylline
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.